About Us

NOvate Medical Technologies is a New Orleans-based medical device development company, focused on commercializing high-quality, low-cost, and sustainable medical products while addressing critical global health needs. NOvate’s first product offering, InfaClip, previously known as SafeSnip, is a patented disposable plastic obstetric device that simultaneously cuts, clamps, and shields the infant, mother, and birthing attendant from infection, aimed at reducing maternal and neonatal mortality in developing countries.

bill_strobel

William Strobel, MBA
Chief Executive Officer

Bill has extensive global experience marketing, manufacturing, and developing products in the technology industry. He is a former Vice President of sales, marketing, and product development for a Fortune 500 company. In addition, he was the President of a $650M division of a public company and was responsible for increasing revenues four fold and operating income fifteen fold in four years. In addition, as CEO of a technology company, he raised $10M of private equity and transitioned an IP company into a product manufacturing platform, marketing products to Fortune 100 customers in energy, communications, and oil and gas markets.

william_kethman

William Kethman, MD
Chief Technology Officer, Founder
@wkethman

William received a degree in Biomedical Engineering and a Medical Doctorate from Tulane University in New Orleans, Louisiana. He is currently completing a Surgical Residency at Stanford University and has helped developed many novel and innovative technologies. William is responsible for guiding NOvate’s clinical and technical activities.

marissa_strobel

Marissa Strobel
Marketing Director
@novatemed

Marissa graduated with a degree in Advertising from the University of Texas at Austin and has worked in the marketing and advertising industry for 5 years. She has helped many large and small ventures build both brand and direct response strategies, as well as executed advertising plans to increase return on investment and brand affinity.